This inventor holds 1 USPTO granted patent. Top assignees: The University of Texas System, University of Oklahoma. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Xue Cai: Innovator in Cell Isolation Technologies
Introduction
Xue Cai is a notable inventor based in Edmond, OK (US). He has made significant contributions to the field of cell biology through his innovative patent. His work focuses on the isolation of migratory cell populations, which has important implications for medical research and therapies.
Latest Patents
Xue Cai holds a patent titled "Devices and methods for isolating a migratory cell population." This patent describes a method and device for isolating a migratory cell population from a mixed population of migratory and non-migratory cells. The method involves placing the mixed population in contact with a device featuring one or more microchannels. Following an incubation period, the migratory cell population is isolated within the microchannels, which are designed with an average size that is less than the minimum proliferation space of the migratory cells along the proliferation direction. This innovative approach enhances the efficiency of cell isolation processes.
Career Highlights
Throughout his career, Xue Cai has worked with prestigious institutions, including the University of Texas System and the University of Oklahoma. His experience in these organizations has allowed him to develop and refine his research in cell isolation technologies.
Collaborations
Xue Cai has collaborated with several professionals in his field, including Young-Tae Kim and Loan Bui. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Xue Cai's innovative work in isolating migratory cell populations showcases his expertise and dedication to advancing cell biology. His contributions are expected to have a lasting impact on medical research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile